Lineage Cell Therapeutics, Inc. (LCTX) Revenue & EPS Growth Rates 2026

Growth Analysis - LCTX

Financial Metrics

Revenue Trends

Period:

CAGR Performance

Revenue

1Y Growth53.24%

5Y CAGR79.88%

10Y CAGR19.10%

Net Income

1Y GrowthN/A

5Y CAGRN/A

10Y CAGRN/A

EPS

1Y GrowthN/A

5Y CAGRN/A

10Y CAGRN/A

EBIT

1Y GrowthN/A

5Y CAGRN/A

10Y CAGRN/A

EBITDA

1Y GrowthN/A

5Y CAGRN/A

10Y CAGRN/A

Capex

1Y Growth-7.61%

5Y CAGR52.16%

10Y CAGR-20.74%

Equity

1Y Growth-43.16%

5Y CAGR-14.27%

10Y CAGR5.18%

Cash Flow

1Y GrowthN/A

5Y CAGRN/A

10Y CAGRN/A

Historical CAGR

Year	1Y CAGR	2Y CAGR	3Y CAGR	5Y CAGR	10Y CAGR	15Y CAGR	20Y CAGR	30Y CAGR
FY 2025 Dec 31, 2025	53.2%	27.6%	-0.3%	79.9%	19.1%	9.6%	14.9%	18.1%
FY 2024 Dec 31, 2024	6.2%	-19.6%	34.6%	45.1%	17.2%	11.2%	14.0%	16.4%
FY 2023 Dec 31, 2023	-39.2%	51.5%	126.2%	44.6%	12.1%	12.6%	14.9%	16.2%
FY 2022 Dec 31, 2022	277.4%	336.1%	115.1%	52.3%	24.1%	19.3%	19.9%	18.1%
FY 2021 Dec 31, 2021	404.0%	62.4%	40.1%	11.6%	-1.1%	8.4%	17.6%	N/A
FY 2020 Dec 31, 2020	-47.7%	-26.1%	-24.4%	-21.1%	-14.4%	-1.0%	14.4%	N/A
FY 2019 Dec 31, 2019	4.4%	-9.2%	-13.1%	-5.4%	-2.6%	5.2%	1.8%	N/A
FY 2018 Dec 31, 2018	-21.0%	-20.7%	-17.6%	-13.1%	-0.6%	6.4%	8.1%	N/A
FY 2017 Dec 31, 2017	-20.4%	-15.9%	-2.7%	1.1%	5.5%	10.8%	15.5%	N/A
FY 2016 Dec 31, 2016	-11.1%	7.6%	-7.7%	-12.4%	6.8%	19.7%	16.8%	N/A
FY 2015 Dec 31, 2015	30.2%	-5.9%	14.4%	-7.2%	10.9%	29.5%	17.5%	N/A
FY 2014 Dec 31, 2014	-32.0%	7.2%	-23.5%	0.2%	11.0%	4.3%	16.0%	N/A
FY 2013 Dec 31, 2013	69.0%	-18.9%	-8.1%	13.7%	17.8%	16.2%	18.3%	N/A
FY 2012 Dec 31, 2012	-61.1%	-32.2%	-4.2%	10.1%	15.9%	20.8%	15.2%	N/A
FY 2011 Dec 31, 2011	18.3%	50.4%	42.5%	30.2%	39.9%	28.6%	N/A	N/A
FY 2010 Dec 31, 2010	91.2%	56.4%	52.1%	32.4%	53.0%	27.2%	N/A	N/A
FY 2009 Dec 31, 2009	28.0%	35.7%	18.3%	22.8%	6.4%	21.8%	N/A	N/A
FY 2008 Dec 31, 2008	43.7%	13.8%	18.5%	22.0%	17.5%	19.8%	N/A	N/A
FY 2007 Dec 31, 2007	-10.0%	7.6%	15.0%	22.0%	26.5%	16.9%	N/A	N/A
FY 2006 Dec 31, 2006	28.7%	29.9%	27.8%	50.2%	27.8%	N/A	N/A	N/A
FY 2005 Dec 31, 2005	31.2%	27.4%	32.6%	76.7%	24.6%	N/A	N/A	N/A
FY 2004 Dec 31, 2004	23.7%	33.4%	65.5%	-7.9%	21.3%	N/A	N/A	N/A
FY 2003 Dec 31, 2003	43.8%	91.4%	119.7%	13.2%	18.7%	N/A	N/A	N/A
FY 2002 Dec 31, 2002	154.8%	171.5%	-28.0%	31.1%	14.5%	N/A	N/A	N/A
FY 2001 Dec 31, 2001	189.4%	-61.7%	-20.3%	8.7%	N/A	N/A	N/A	N/A
FY 2000 Dec 31, 2000	-94.9%	-58.2%	-19.3%	-12.1%	N/A	N/A	N/A	N/A
FY 1999 Dec 31, 1999	245.8%	222.1%	118.1%	59.7%	N/A	N/A	N/A	N/A
FY 1998 Dec 31, 1998	200.0%	73.2%	44.2%	24.6%	N/A	N/A	N/A	N/A
FY 1997 Jun 30, 1998	0.0%	0.0%	0.0%	0.0%	N/A	N/A	N/A	N/A
FY 1996 Jun 30, 1996	0.0%	0.0%	0.0%	N/A	N/A	N/A	N/A	N/A
FY 1995 Jun 30, 1995	0.0%	0.0%	0.0%	N/A	N/A	N/A	N/A	N/A
FY 1994 Jun 30, 1994	0.0%	0.0%	N/A	N/A	N/A	N/A	N/A	N/A
FY 1993 Jun 30, 1993	0.0%	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FY 1992 Jun 30, 1992	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Growth Analysis - LCTX

Financial Metrics

Revenue Trends

Period:

CAGR Performance

Revenue

1Y Growth53.24%

5Y CAGR79.88%

10Y CAGR19.10%

Net Income

1Y GrowthN/A

5Y CAGRN/A

10Y CAGRN/A

EPS

1Y GrowthN/A

5Y CAGRN/A

10Y CAGRN/A

EBIT

1Y GrowthN/A

5Y CAGRN/A

10Y CAGRN/A

EBITDA

1Y GrowthN/A

5Y CAGRN/A

10Y CAGRN/A

Capex

1Y Growth-7.61%

5Y CAGR52.16%

10Y CAGR-20.74%

Equity

1Y Growth-43.16%

5Y CAGR-14.27%

10Y CAGR5.18%

Cash Flow

1Y GrowthN/A

5Y CAGRN/A

10Y CAGRN/A

Historical CAGR

Year	1Y CAGR	2Y CAGR	3Y CAGR	5Y CAGR	10Y CAGR	15Y CAGR	20Y CAGR	30Y CAGR
FY 2025 Dec 31, 2025	53.2%	27.6%	-0.3%	79.9%	19.1%	9.6%	14.9%	18.1%
FY 2024 Dec 31, 2024	6.2%	-19.6%	34.6%	45.1%	17.2%	11.2%	14.0%	16.4%
FY 2023 Dec 31, 2023	-39.2%	51.5%	126.2%	44.6%	12.1%	12.6%	14.9%	16.2%
FY 2022 Dec 31, 2022	277.4%	336.1%	115.1%	52.3%	24.1%	19.3%	19.9%	18.1%
FY 2021 Dec 31, 2021	404.0%	62.4%	40.1%	11.6%	-1.1%	8.4%	17.6%	N/A
FY 2020 Dec 31, 2020	-47.7%	-26.1%	-24.4%	-21.1%	-14.4%	-1.0%	14.4%	N/A
FY 2019 Dec 31, 2019	4.4%	-9.2%	-13.1%	-5.4%	-2.6%	5.2%	1.8%	N/A
FY 2018 Dec 31, 2018	-21.0%	-20.7%	-17.6%	-13.1%	-0.6%	6.4%	8.1%	N/A
FY 2017 Dec 31, 2017	-20.4%	-15.9%	-2.7%	1.1%	5.5%	10.8%	15.5%	N/A
FY 2016 Dec 31, 2016	-11.1%	7.6%	-7.7%	-12.4%	6.8%	19.7%	16.8%	N/A
FY 2015 Dec 31, 2015	30.2%	-5.9%	14.4%	-7.2%	10.9%	29.5%	17.5%	N/A
FY 2014 Dec 31, 2014	-32.0%	7.2%	-23.5%	0.2%	11.0%	4.3%	16.0%	N/A
FY 2013 Dec 31, 2013	69.0%	-18.9%	-8.1%	13.7%	17.8%	16.2%	18.3%	N/A
FY 2012 Dec 31, 2012	-61.1%	-32.2%	-4.2%	10.1%	15.9%	20.8%	15.2%	N/A
FY 2011 Dec 31, 2011	18.3%	50.4%	42.5%	30.2%	39.9%	28.6%	N/A	N/A
FY 2010 Dec 31, 2010	91.2%	56.4%	52.1%	32.4%	53.0%	27.2%	N/A	N/A
FY 2009 Dec 31, 2009	28.0%	35.7%	18.3%	22.8%	6.4%	21.8%	N/A	N/A
FY 2008 Dec 31, 2008	43.7%	13.8%	18.5%	22.0%	17.5%	19.8%	N/A	N/A
FY 2007 Dec 31, 2007	-10.0%	7.6%	15.0%	22.0%	26.5%	16.9%	N/A	N/A
FY 2006 Dec 31, 2006	28.7%	29.9%	27.8%	50.2%	27.8%	N/A	N/A	N/A
FY 2005 Dec 31, 2005	31.2%	27.4%	32.6%	76.7%	24.6%	N/A	N/A	N/A
FY 2004 Dec 31, 2004	23.7%	33.4%	65.5%	-7.9%	21.3%	N/A	N/A	N/A
FY 2003 Dec 31, 2003	43.8%	91.4%	119.7%	13.2%	18.7%	N/A	N/A	N/A
FY 2002 Dec 31, 2002	154.8%	171.5%	-28.0%	31.1%	14.5%	N/A	N/A	N/A
FY 2001 Dec 31, 2001	189.4%	-61.7%	-20.3%	8.7%	N/A	N/A	N/A	N/A
FY 2000 Dec 31, 2000	-94.9%	-58.2%	-19.3%	-12.1%	N/A	N/A	N/A	N/A
FY 1999 Dec 31, 1999	245.8%	222.1%	118.1%	59.7%	N/A	N/A	N/A	N/A
FY 1998 Dec 31, 1998	200.0%	73.2%	44.2%	24.6%	N/A	N/A	N/A	N/A
FY 1997 Jun 30, 1998	0.0%	0.0%	0.0%	0.0%	N/A	N/A	N/A	N/A
FY 1996 Jun 30, 1996	0.0%	0.0%	0.0%	N/A	N/A	N/A	N/A	N/A
FY 1995 Jun 30, 1995	0.0%	0.0%	0.0%	N/A	N/A	N/A	N/A	N/A
FY 1994 Jun 30, 1994	0.0%	0.0%	N/A	N/A	N/A	N/A	N/A	N/A
FY 1993 Jun 30, 1993	0.0%	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FY 1992 Jun 30, 1992	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Growth Analysis - LCTX

Financial Metrics

Revenue Trends

CAGR Performance

Revenue

Net Income

EPS

EBIT

EBITDA

Capex

Equity

Cash Flow

Historical CAGR

More on Lineage Cell Therapeutics, Inc.

Compare with peers

Explore

Growth Analysis - LCTX

Financial Metrics

Revenue Trends

CAGR Performance

Revenue

Net Income

EPS

EBIT

EBITDA

Capex

Equity

Cash Flow

Historical CAGR

More on Lineage Cell Therapeutics, Inc.

Compare with peers

Explore